Science AI Journal
Neuroscience · Research topic

Open research questions in Tryptophan and brain disorders

747 gap statements mined from Tryptophan and brain disorders papers in our 7.9M-paper local library, which holds 2,705 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.

Choosing where to publish on Tryptophan and brain disorders? See the ranked Biology journals.

What the literature leaves open

  • It highlights the need for a biomarker-guided approach to patient stratification. The paper notes the complexity of the immune system and its role in MDD.

    Immunotherapy for depression: targeting cytokine pathways in major depressive disorder · 2026 · DOI

  • The underlying mechanisms of pediatric OCD are not fully understood. There is a need to investigate the potential role of kynurenine pathway and inflammation in pediatric OCD. Prior studies have not compared serum levels of KP metabolites and inflammatory markers among drug-naïve children and adolescents diagnosed with OCD, OCD + MDD, and a healthy control group.

    The potential role of kynurenine pathway and inflammation in pediatric obsessive-compulsive disorder with and without major depressive disorder comorbidity · 2026 · DOI

  • The need to optimize the activities of the biosensor by employing appropriate reagent concentrations. The challenge of selectively capturing IDO-1 and IFN-γ from a large sample matrix. The requirement for precise angle selection and acquisition of a series of images across a defined angular range.

    Carboxymethyl Dextran-Based Biosensor for Simultaneous Determination of IDO-1 and IFN-Gamma in Biological Material · 2025 · DOI

  • The need for a novel method for simultaneous quantitative determination of IDO-1 and IFN-γ in biological samples. The lack of a sensitive and precise biosensor for detecting IDO-1 and IFN-γ.

    Carboxymethyl Dextran-Based Biosensor for Simultaneous Determination of IDO-1 and IFN-Gamma in Biological Material · 2025 · DOI

  • The limited understanding of the underlying mechanism of paeoniflorin's antidepressant effects poses a challenge. The development of effective therapeutic strategies for depression is a significant challenge.

    Paeoniflorin Inhibits the Activation of Microglia and Alleviates Depressive Behavior by Regulating SIRT1-NF-kB-NLRP3/Pyroptosis Pathway · 2024 · DOI

  • The current treatment options for depression have limitations, including low cure rates and serious side effects. The underlying mechanism of paeoniflorin's antidepressant effects is not fully understood. The relationship between depression, inflammation, and pyroptosis requires further exploration.

    Paeoniflorin Inhibits the Activation of Microglia and Alleviates Depressive Behavior by Regulating SIRT1-NF-kB-NLRP3/Pyroptosis Pathway · 2024 · DOI

  • The specific mechanisms of depression have not been fully clarified. The potential biological mechanisms underlying baicalin's antidepressant effect are still unclear. Studying just one signaling pathway is insufficient to fully elucidate the specific mechanism of baicalin's antidepressant effect.

    Baicalin Ameliorates Depression-like Behaviors via Inhibiting Neuroinflammation and Apoptosis in Mice · 2024 · DOI

  • The involvement of the immune system in the pathogenesis of neurological diseases has been overlooked. The role of kynurenine and its derivatives in the neuroimmune system is not fully understood.

    Role of Kynurenine and Its Derivatives in the Neuroimmune System · 2024 · DOI

  • However, current evidence is limited by small sample sizes, study heterogeneity, and lack of replication.

    Tryptophan Metabolic Dysregulation in Schizophrenia Pathogenesis and Therapeutic Implications · 2026 · DOI

  • Major Depressive Disorder (MDD) with atypical features, briefly named Atypical Depression (AFD), exhibits affective instability and metabolic-immune abnormalities, yet objective biomarkers remain lacking.

    Exploratory Longitudinal Pilot Study of Proteomic and Metabolomic Profiling Suggests a Hypothesized PIAS4-NF-κB-Stearic Acid Model in Atypical Depression · 2026 · DOI

  • Fatigue is a common and debilitating symptom in Inflammatory Bowel Disease(1), but its underlying mechanisms remain unclear(2).

    P0058 Altered tryptophan metabolism is associated with severe fatigue in quiescent Crohn’s Disease · 2026 · DOI

  • Acute inflammatory challenge has been shown to induce transient anhedonia and reward processing deficits, but its effects on distinct components of social reward processes remain poorly understood.

    Effects of acute inflammatory challenge on anhedonia and social reward processing: A randomized controlled trial of endotoxin · 2026 · DOI

  • However, it remains unclear whether different combinations of inflammatory and metabolic burden define distinct clinical depressive phenotypes.

    Differential associations of inflammatory-metabolic markers with depressive symptom dimensions: Towards a clinical phenotyping of immune-metabolic depression · 2026 · DOI

  • Soluble Triggering Receptor Expressed on Myeloid Cells-1 and -2 (sTREM1, sTREM2) and Fractalkine (CX3CL1) are markers of the innate immune system regulating inflammatory response but are relatively underexplored in ACE and MDD.

    Analysis of Soluble Triggering Receptor Expressed on Myeloid Cells-1 and -2 and Fractalkine in Depression and Childhood Adversity: An Exploratory Study · 2026 · DOI

  • Chronic stress contributes to comorbid hyperalgesia and depression-like behaviors, but the microbial-metabolic mediators linking stress to these phenotypes remain unclear.

    Microbiota-derived tryptophol attenuates chronic stress-induced pain- and depression-like phenotypes in female mice via colonic aryl hydrocarbon receptor signaling through reduced neuroinflammation · 2026 · DOI

  • As the pathogenesis remains poorly understood, the currently available treatment regimens are mostly symptomatic therapies with little satisfactory curative effect.

    Lignans Alleviate Depression by Modulating the Gut–Brain Axis: Effect and Mechanism Based on Multi‐Omics Analyses · 2026 · DOI

  • Emerging evidence suggests a bidirectional relationship between inflammation and sleep disturbances, but the role of peripheral inflammatory markers in subjective sleep quality in treatment-resistant depression (TRD) remains unclear.

    Associations between subjective sleep quality and inflammatory markers in patients with treatment-resistant depression · 2025 · DOI

  • Major Depressive Disorder (MDD) is closely associated with neuroinflammation, but the underlying mechanisms remain to be fully elucidated.

    NPAS2 Deficiency Leads to Antidepressant‐Like Behaviors in Mice by Modulating Astrocyte‐Mediated Neuroinflammation · 2025 · DOI

  • Major depressive disorder (MDD) exhibits a high prevalence among adolescents; however, its pathogenesis remains unclear.

    Peripheral cytokine dysregulation, microglial dysfunction in adolescent major depressive disorder: Neuroimmune crosstalk implications · 2025 · DOI

  • Although current clinical trials of anti-inflammatory treatments show promise, findings remain inconsistent.

    Understanding late-life depression: focus on inflammation · 2025 · DOI

  • Future research should focus on identifying inflammatory subtypes of LLD and validating personalized, mechanism-based interventions to improve treatment outcomes in aging populations.

    Understanding late-life depression: focus on inflammation · 2025 · DOI

  • The cross-sectional nature of the study limits its ability to determine causality. The study requires additional prospective longitudinal studies for further elucidation. Signal cross-talk and cross-reactivity can influence the absolute quantification of cytokines, requiring cautious interpretation of the findings.

    Cytokines and cognitive function in first-episode drug-naïve MDD: an inflammation panel perspective · 2026 · DOI

  • The difficulty of working with 11C-based tracers, which have an extremely short half-life of 20.3 min. The requirement for cyclotron production of 11C-based tracers. The limited availability of research facilities with access to a cyclotron.

    Tryptophan-Based Imaging Agents for Major Depressive Disorders · 2026 · DOI

  • Biomarker-guided patient stratification and standardized inflammatory profiling are needed - Rigorously designed clinical trials are necessary to establish both efficacy and safety…

    Immunotherapy for depression: targeting cytokine pathways in major depressive disorder · 2026 · DOI

  • The study has a cross-sectional nature and cannot determine causality, - Additional independent samples and molecular biology experiments are required to validate the roles of cytokine subtypes in MDD pathogenesis, - The HAMD-17 and HAMA scales were not administered to HCs, - After Bonferroni correction, the associations did not remain statistically…

    Cytokines and cognitive function in first-episode drug-naïve MDD: an inflammation panel perspective · 2026 · DOI

Most-cited papers in Tryptophan and brain disorders

Most recent work

Find a gap in your own Tryptophan and brain disorders sub-topic

This page shows what the Tryptophan and brain disorders literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Neuroscience

Autism Spectrum Disorder Research
2,256 open questions
Functional Brain Connectivity Studies
1,332 open questions
Neuroinflammation and Neurodegeneration Mechanisms
1,210 open questions
Neural and Behavioral Psychology Studies
1,042 open questions
Transcranial Magnetic Stimulation Studies
963 open questions
EEG and Brain-Computer Interfaces
832 open questions
Neurobiology of Language and Bilingualism
825 open questions
Hearing Loss and Rehabilitation
815 open questions
Open questions raised by papers listed on this page include: (1) The underlying mechanisms of pediatric OCD are not fully understood (“The potential role of kynurenine pathway and inflammation in pediatric…”, 2026); (2) Current evidence is limited by small sample sizes, study heterogeneity, and lack of replication (“Tryptophan Metabolic Dysregulation in Schizophrenia Pathogenesis and…”, 2026); (3) Acute inflammatory challenge has been shown to induce transient anhedonia and reward processing deficits, but its effects on distinct components of social reward processes remain poorly understood (“Effects of acute inflammatory challenge on anhedonia and social reward…”, 2026); (4) It remains unclear whether different combinations of inflammatory and metabolic burden define distinct clinical depressive phenotypes (“Differential associations of inflammatory-metabolic markers with depressive…”, 2026); (5) Chronic stress contributes to comorbid hyperalgesia and depression-like behaviors, but the microbial-metabolic mediators linking stress to these phenotypes remain unclear (“Microbiota-derived tryptophol attenuates chronic stress-induced pain- and…”, 2026). 747 gap statements have been mined from Tryptophan and brain disorders papers in our 7.9M-paper local library, which holds 2,705 papers on the topic; the gaps come from whichever of those papers state one. They are mostly the research gaps the authors state and the papers' abstracts, plus future-work, limitations and challenges passages. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 1,100,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? Acceptance odds for top, mid and open/emerging journals, in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck for prior publication across 7 sources and our local library.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.